Insights On Drug Development
-
Managing Endotoxins - Detect, Prevent, Remove
9/8/2025
Explore the risks of endotoxin contamination in drug manufacturing and discover sustainable, animal-free detection methods to ensure pharmaceutical safety and regulatory compliance.
-
Strategic Approaches To Controlled Release Formulation: Polymer Screening And Case Study Insights
9/4/2025
Discover how early polymer selection drives formulation success, with case studies linking polymer choice to drug release and practical insights for developing robust CR products.
-
Liposomal And Nanoparticle Technology
9/3/2025
Specializing in oncology, anti-infective, and complex formulations, Pfizer Melbourne provides manufacturing services for sterile dosage forms.
-
Accelerating IND-Enabling Studies With Automated Bioanalysis Workflows
9/2/2025
Reimagined as automation-first, bioanalysis shifts from being an Investigational New Drug (IND) bottleneck to a catalyst for innovation—helping companies move therapies forward with greater confidence.
-
Why Bioanalysis Needs To Break Free From Manual Bottlenecks
9/2/2025
Bioanalysis remains one of the most persistent bottlenecks in drug development, with CRO's displaying inefficiencies that are no longer operational nuisances but strategic liabilities.
-
How CRISPR And LNP Accelerate Therapeutic Innovation Through Analytics
9/2/2025
CRISPR gene editing and lipid nanoparticle delivery are revolutionizing precision medicine. Discover how optimized LNP systems and advanced analytics accelerate therapeutic development.
-
N-1 Perfusion Strategies For Commercial-Ready Biologics
8/27/2025
Learn how an approach with modular N-1 perfusion strategies shortens seed train timelines and reduces facility strain — enabling upstream processes that scale efficiently and reliably for commercial manufacturing.
-
Overcoming Challenges In Ophthalmic Formulations Through Polymer Selection
8/27/2025
The growing demand for ophthalmic drugs is driven by aging populations and increased screen time, which contributes to rising eye conditions. Explore innovative solutions in ophthalmic drug development.
-
Overcoming Challenges In Ophthalmic Formulations
8/27/2025
Discover key strategies for overcoming formulation challenges in ophthalmic drug development and learn how selecting the right excipients supports quality, compliance, and safety.
-
Overcoming Excipient Risks And Challenges For Parenteral Formulations
8/27/2025
Excipients are essential to parenteral formulations, which help protect APIs, enhance stability, and ensure safety. Learn how strategic excipient selection can optimize drug performance and patient outcomes.